IDH1 and central nervous system cancer: Similar results were obtained using Visually AcceSAble Rembrandt Images integrated with radiomic features to predict IDH wild-type lower-grade gliomas (II/III) that carry molecular features such as epidermal growth factor receptor (EGFR) amplification or telomerase reverse transcriptase (TERT) promoter mutations, which are reported to behave similarly to glioblastomas [32].